Corrigendum to "Transdermal alcohol concentration data collected during a contingency management program to reduce at-risk drinking" [Drug and Alcohol Dependence, 148, (2015), 77-84 doi: 10.1016/j.drugalcdep.2014.12.021];Transdermal alcohol concentration data collected during a contingency management program to reduce at-risk drinking

Drug and Alcohol Dependence

Volumn 148, Issue , 2015, Pages 77-84

  Dougherty, Donald M ^a   Karns, Tara E ^a   Mullen, Jillian ^a   Liang, Yuanyuan ^a   Lake, Sarah L ^a   Roache, John D ^a   Hill Kapturczak, Nathalie ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Alcohol; Alcohol detection; Harm reduction; Transdermal alcohol monitoring

Indexed keywords

ALCOHOL;

ADULT; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOL REHABILITATION PROGRAM; ALCOHOL USE DISORDER; ARTICLE; CONCENTRATION (PARAMETERS); CONTINGENCY MANAGEMENT; DRINKING BEHAVIOR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; RISK REDUCTION; TRANSDERMAL ALCOHOL CONCENTRATION; AMBULATORY MONITORING; BEHAVIOR THERAPY; DISEASE MANAGEMENT; FOLLOW UP; HIGH RISK BEHAVIOR; PREVENTION AND CONTROL; PROCEDURES; PSYCHOLOGY; SELF REPORT; SKIN ABSORPTION; TRENDS; YOUNG ADULT;

ADULT; ALCOHOL DRINKING; BEHAVIOR THERAPY; DISEASE MANAGEMENT; ETHANOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MONITORING, AMBULATORY; RISK-TAKING; SELF REPORT; SKIN ABSORPTION; YOUNG ADULT;

EID: 84923069396     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2015.01.037     Document Type: Erratum

References (59)

1. Adamson S.J., Heather N., Morton V., Raistrick D., Team U.R. Initial preference for drinking goal in the treatment of alcohol problems: II. Treatment outcomes. Alcohol Alcohol. 2010, 45:136-142.
2. Adamson S.J., Sellman J.D. Drinking goal selection and treatment outcome in out-patients with mild-moderate alcohol dependence. Drug Alcohol Rev. 2001, 20:351-359.
3. Aklin W.M., Wong C.J., Hampton J., Svikis D.S., Stitzer M., Bigelow G.E., Silverman K. A therapeutic workplace for the long-term treatment of drug addiction and unemployment: eight-year outcomes of a social business intervention. J. Subst. Abuse Treat. 2014, 47:329-338.
4. Ambrogne J.A. Reduced-risk drinking as a treatment goal: what clinicians need to know. J. Subst. Abuse Treat. 2002, 22:45-53.
5. Anton R.F., Lieber C., Tabakoff B., Group C.D.S. Carbohydrate-deficient transferrin and gamma-glutamyltransferase for the detection and monitoring of alcohol use: results from a multisite study. Alcohol. Clin. Exp. Res. 2002, 26:1215-1222.
6. Barnett N.P., Tidey J., Murphy J.G., Swift R., Colby S.M. Contingency management for alcohol use reduction: a pilot study using a transdermal alcohol sensor. Drug Alcohol Depend. 2011, 118:391-399.
7. Barnett N.P., Meade E.B., Glynn T.R. Predictors of detection of alcohol use episodes using a transdermal alcohol sensor. Exp. Clin. Psychopharmacol. 2014, 22:86-96.
8. Chutuape M.A., Silverman K., Stitzer M.L. Use of methadone take-home contingencies with persistent opiate and cocaine abusers. J. Subst. Abuse Treat. 1999, 16:23-30.
9. DeMartini K.S., Devine E.G., DiClemente C.C., Martin D.J., Ray L.A., O'Malley S.S. Predictors of pretreatment commitment to abstinence: results from the COMBINE study. J. Stud. Alcohol Drugs 2014, 75:438.
10. de Visser R.O., Birch J.D. My cup runneth over: young people's lack of knowledge of low-risk drinking guidelines. Drug Alcohol Rev. 2012, 31:206-212.
11. Devos-Comby L., Lange J.E. Standardized measures of alcohol-related problems: a review of their use among college students. Psychol. Addict. Behav. 2008, 22:349-361.
12. Dougherty D.M., Charles N.E., Acheson A., John S., Furr R.M., Hill-Kapturczak N. Comparing the detection of transdermal and breath alcohol concentrations during periods of alcohol consumption ranging from moderate drinking to binge drinking. Exp. Clin. Psychopharmacol. 2012, 20:373-381.
13. Dougherty D.M., Hill-Kapturczak N., Liang Y., Karns T.E., Cates S.E., Lake S.L., Mullen J., Roache J.D. Use of continuous transdermal alcohol monitoring during a contingency management procedure to reduce excessive alcohol use. Drug Alcohol Depend. 2014, 142:301-306.
14. Dougherty D.M., Lake S.L., Hill-Kapturczak N., Liang Y., Karns T., Mullen J., Roache J.D. Using contingency management procedures to reduce at-risk drinking in heavy drinkers. Alcohol. Clin. Exp. Res. 2014, Manuscript under review.
15. Engasser J.L., Hermos J.A., Rubin A., Lachowicz M., Rybin D., Brief D.J., Roy M., Helmuth E., Rosenbloom D., Keane T.M. Drinking goal choice and outcomes in a web-based alcohol intervention: results from VetChange. Addict. Behav. 2015, 42:63-68.
16. Finlay A.K., Ram N., Maggs J.L., Caldwell L.L. Leisure activities, the social weekend, and alcohol use: evidence from a daily study of firsty-year college students. J. Stud. Alcohol Drugs 2012, 73:250-259.
17. First M.B., Spitzer R.L., Givvon M., Williams J.B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition (SCID-I/NP) 2001, Biometrics Research, New York State Psychiatric Institute, New York.
18. Garcia-Rodriguez O., Secades-Villa R., Higgins S.T., Fernandez-Hermida J.R., Carballo J.L., Errasti Perez J.M., Al-halabi Diaz S. Effects of voucher-based intervention on abstinence and retention in an outpatient treatment for cocaine addiction: a randomized controlled trial. Exp. Clin. Psychopharmacol. 2009, 17:131-138.
19. Gastfriend D.R., Garbutt J.C., Pettinati H.M., Forman R.F. Reduction in heavy drinking as a treatment outcome in alcohol dependence. J. Subst. Abuse Treat. 2007, 33:71-80.
20. Haines P.S., Hama M.Y., Guilkey D.K., Popkin B.M. Weekend eating in the United States is linked with greater energy, fat, and alcohol intake. Obesity Res. 2003, 11:945-949.
21. Hartzler B., Lash S.J., Roll J.M. Contingency management in substance abuse treatment: a structured review of the evidence for its transportability. Drug Alcohol Depend. 2012, 122:1-10.
22. Heather N., Adamson S.J., Raistrick D., Slegg G.P. Initial preference for drinking goal in the treatment of alcohol problems: I. Baseline differences between abstinence and non-abstinence groups. Alcohol Alcohol. 2010, 45:128-135.
23. Helander A., Jaeken J., Matthijs G., Eggertsen G. Asymptomatic phosphomannose isomerase deficiency (MPI-CDG) initially mistaken for excessive alcohol consumption. Clin. Chim. Acta 2014, 431:15-18.
24. Higgins S.T., Budney A.J., Bickel W.K. Applying behavioral concepts and principles to the treatment of cocaine dependence. Drug Alcohol Depend. 1994, 34:87-97.
25. Higgins S.T., Delaney D.D., Budney A.J., Bickel W.K., Hughes J.R., Foerg F., Fenwick J.W. A behavioral approach to achieving initial cocaine abstinence. Am. J. Psychiatry 1991, 148:1218-1224.
26. Hill-Kapturczak N., Roache J.D., Liang Y.Y., Karns T.E., Cates S.E., Dougherty D.M. Accounting for sex-related differences in the estimation of breath alcohol levels using transdermal alcohol monitoring. Psychopharmacol 2015, 232:115-123.
27. Hser Y.I., Li J., Jiang H., Zhang R., Du J., Zhang C., Zhang B., Evans E., Wu F., Chang Y.J., Peng C., Huang D., Stitzer M.L., Roll J., Zhao M. Effects of a randomized contingency management intervention on opiate abstinence and retention in methadone maintenance treatment in China. Addiction 2011, 106:1801-1809.
28. Javors M.A., Johnson B.A. Current status of carbohydrate deficient transferrin, total serum sialic acid, sialic acid index of apolipoprotein J and serum beta-hexosaminidase as markers for alcohol consumption. Addiction 2003, 98:45-50.
29. Kerr W.C., Stockwell T. Understanding standard drinks and drinking guidelines. Drug Alcohol Rev. 2012, 31:200-205.
30. Kranzler H.R., Wesson D.R., Billot L., DrugAbuse Sciences Naltrexone Depot Study G. Naltrexone depot for treatment of alcohol dependence: a multicenter, randomized, placebo-controlled clinical trial. Alcohol. Clin. Exp. Res. 2004, 28:1051-1059.
31. Kuntsche E., Cooper M.L. Drinking to have fun and to get drunk: motives as predictors of weekend drinking over and above usual drinking habits. Drug Alcohol Depend. 2010, 110:259-262.
32. Maenhout T.M., De Buyzere M.L., Delanghe J.R. Non-oxidative ethanol metabolites as a measure of alcohol intake. Clin. Chim. Acta 2013, 415:322-329.
33. Mann K., Bladstrom A., Torup L., Gual A., van den Brink W. Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene. Biol. Psychiatry 2013, 73:706-713.
34. Markway E.C., Baker S.N. A review of the methods, interpretation, and limitations of the urine drug screen. Orthopedics 2011, 34:877-881.
35. Marlatt G.A., Witkiewitz K. Harm reduction approaches to alcohol use: health promotion, prevention, and treatment. Addict. Behav. 2002, 27:867-886.
36. May P.A., Gossage J.P. Maternal risk factors for fetal alcohol spectrum disorders: not as simple as it might seem. Alcohol Res. Health 2011, 34:15-26.
37. McDonell M.G., Howell D.N., McPherson S., Cameron J.M., Srebnik D., Roll J.M., Ries R.K. Voucher-based reinforcement for alcohol abstinence using the ethyl-glucuronide alcohol biomarker. J. Appl. Behav. Anal. 2012, 45:161-165.
38. Moos R., Moos B. Long-term influence of duration and intensity of treatment on previously untreated individuals with alcohol use disorders. Addiction 2003, 98:325-337.
39. Muñiz-Hernández S., Velázquez-Fernández J.B., Díaz-Chávez J., López-Sánchez R.C., Hernández J.A., Rendón-Ramírez A. Alcoholism: common and oxidative damage biomarkers. J. Clin. Toxicol. 2014, S7, S7-006.
40. National Institute on Alcohol Abuse and Alcoholism (NIAAA) Rethinking Drinking. NIH Publication No. 13-3770 2010, U.S. Department of Health and Human Services, Washington, DC.
41. Pettinati H.M., Oslin D.W., Kampman K.M., Dundon W.D., Xie H., Gallis T.L., Dackis C.A., O'Brien C.P. A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence. Am. J. Psychiatry 2010, 167:668-675.
42. Prendergast M., Podus D., Finney J., Greenwell L., Roll J. Contingency management for treatment of substance use disorders: a meta-analysis. Addiction 2006, 101:1546-1560.
43. Rogers R.E., Higgins S.T., Silverman K., Thomas C.S., Badger G.J., Bigelow G., Stitzer M. Abstinence-contingent reinforcement and engagement in non-drug-related activities among illicit drug abusers. Psychol. Addict. Behav. 2008, 22:544-550.
44. Roll J.M., Petry N.M., Stitzer M.L., Brecht M.L., Peirce J.M., McCann M.J., Blaine J., MacDonald M., DiMaria J., Lucero L., Kellogg S. Contingency management for the treatment of methamphetamine use disorders. Am. J. Psychiatry 2006, 163:1993-1999.
45. Rosenberg H., Davis A.K. Differences in the acceptability of non-abstinence goals by type of drug among American substance abuse clinicians. J. Subst. Abuse Treat. 2014, 46:214-218.
46. Sindelar J., Elbel B., Petry N.M. What do we get for our money? Cost-effectiveness of adding contingency management. Addiction 2007, 102:309-316.
47. Sindelar J.L., Olmstead T.A., Peirce J.M. Cost-effectiveness of prize-based contingency management in methadone maintenance treatment programs. Addiction 2007, 102:1463-1471.
48. Simpson D.D., Joe G.W., Brown B.S. Treatment retention and follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychol. Addict. Behav. 1997, 11:294-307.
49. Skewes M.C., Gonzalez V.M. Attitudes toward harm reduction and abstinence-only approaches to alcohol misuse among Alaskan college students. Int. J. Circumpolar Health 2013, Epub ahead of print.
50. Sobell L.C., Sobell M.B. Timeline Followback: a technique for assessing self-reported ethanol consumption. Measuring Alcohol Consumption: Psychosocial and Biological Methods 1992, 41-72. Humana Press, Totowa, NJ. J. Allen, R.Z. Litten (Eds.).
51. Sobell L.C., Sobell M.B. Alcohol consumption measures. Assessing Alcohol Problems: A guide for Clinicians and Researchers 2003, 77-99. NIH, Bethesda. 2nd edition. J.P. Allen, V.B. Wilson (Eds.).
52. Stitzer M., Bigelow G.E., Liebson I. Reducing drug use among methadone maintenance clients: contingent reinforcement for morphine-free urines. Addict. Behav. 1980, 5:8.
53. Stitzer M., Petry N. Contingency management for treatment of substance abuse. Annu. Rev. Clin. Psychol. 2006, 2:411-434.
54. Swift R. Transdermal alcohol measurement for estimation of blood alcohol concentration. Alcohol. Clin. Exp. Res. 2000, 24:422-423.
55. Swift R. Direct measurement of alcohol and its metabolites. Addiction 2003, 98:73-80.
56. Trim R.S., Schuckit M.A., Smith T.L. Predictors of initial and sustained remission from alcohol use disorders: findings from the 30-year follow-up of the San Diego Prospective Study. Alcohol. Clin. Exp. Res. 2013, 37:1424-1431.
57. Tuithof M., Have M.T., van den Brink W., Vollebergh W., de Graaf R. The relationship between excessive alcohol consumption and alcohol use disorders according to DSM-IV and DSM-5. Alcohol. Clin. Exp. Res. 2014, 38:249-256.
58. Weschler D. Wechsler Abbreviated Scale of Intelligence 1999, The Psychological Corporation Harcourt Brace and Company, New York, NY.
59. White A.M., Kraus C.L., McCracken L.A., Swartzwelder H.S. Do college students drink more than they think? Use of a free-pour paradigm to determine how college students define standard drinks. Alcohol. Clin. Exp. Res. 2003, 27:1750-1756.